X0202 SCHEDULE 13G/A 0001404574 XXXXXXXX LIVE 2 Common Stock, par value $0.0001 per share 03/31/2026 0001280776 IMMUNIC, INC. 4525EP200 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 Rule 13d-1(c) 683 CAPITAL MANAGEMENT, LLC DE 0.00 474200.00 0.00 474200.00 474200.00 N 3.4 IA This Amendment No. 2 constitutes an exit filing for the Reporting Persons (as defined below), as the Reporting Persons no longer beneficially own more than five percent of the outstanding shares of the Issuer. 683 CAPITAL PARTNERS, LP DE 0.00 474200.00 0.00 474200.00 474200.00 N 3.4 PN This Amendment No. 2 constitutes an exit filing for the Reporting Persons (as defined below), as the Reporting Persons no longer beneficially own more than five percent of the outstanding shares of the Issuer. Zweiman Ari X1 0.00 474200.00 0.00 474200.00 474200.00 N 3.4 IN This Amendment No. 2 constitutes an exit filing for the Reporting Persons (as defined below), as the Reporting Persons no longer beneficially own more than five percent of the outstanding shares of the Issuer. IMMUNIC, INC. 1200 Avenue of the Americas, Suite 200, New York, New York 10036 683 Capital Management, LLC 683 Capital Partners, LP Ari Zweiman Each of the foregoing is referred to as a "Reporting Person" and collectively as the "Reporting Persons." The principal business address for each of the Reporting Persons is 1700 Broadway, Suite 4200, New York, NY 10019. 683 Capital Management, LLC - DELAWARE 683 Capital Partners, LP - DELAWARE Ari Zweiman - UNITED STATES Y As of May 15, 2026, 683 Capital Partners, LP beneficially owned (i) 245,000 shares of Common Stock and (ii) warrants to purchase an additional 229,200 shares of Common Stock which are currently exercisable. 683 Capital Management, LLC, as the investment manager of 683 Capital Partners, LP, may be deemed to have beneficially owned (i) 245,000 shares of Common Stock and (ii) warrants to purchase an additional 229,200 shares of Common Stock beneficially owned by 683 Capital Partners, LP. Ari Zweiman, as the Managing Member of 683 Capital Management, LLC, may be deemed to have beneficially owned (i) 245,000 shares of Common Stock and (ii) warrants to purchase an additional 229,200 shares of Common Stock beneficially owned by 683 Capital Management, LLC. The following percentage is based on 13,621,526 shares of Common Stock outstanding as of April 28, 2026, as reported in the Issuer's Registration Statement on Form S-3 filed with the Securities and Exchange Commission on April 30, 2026, plus 229,200 shares of Common Stock issuable upon exercise of currently exercisable warrants held by the Reporting Persons. As of May 15, 2026, the Reporting Persons may be deemed to have beneficially owned a total of 474,200 shares of Common Stock, constituting approximately 3.4% of the outstanding shares of Common Stock. 3.4% See Cover Pages Items 5-9. See Cover Pages Items 5-9. See Cover Pages Items 5-9. See Cover Pages Items 5-9. N Y Y Y N See Exhibit 99.1 to Schedule 13G filed on August 8, 2025. Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. 683 CAPITAL MANAGEMENT, LLC /s/ Ari Zweiman 05/15/2026 683 CAPITAL PARTNERS, LP /s/ Ari Zweiman 05/15/2026 Zweiman Ari /s/ Ari Zweiman 05/15/2026